TY  - RPRT
TI  - Engineering CRISPR nanoplatforms to deplete cancer stem cells: Delivery checkpoints, target plasticity, and clinical viability.
AU  - Selvakumar Chandrasekaran
AU  - Nallusamy Duraisamy
AU  - Manjunathan Jagadeesan
AU  - Yashwanth Kumar Palukuri
AU  - Silambarasan Tamilselvan
PY  - 2026
DO  - 10.1016/j.nano.2026.103007
UR  - https://pubmed.ncbi.nlm.nih.gov/42641742/
ID  - 42641742
ER  -